Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elisa Kucia

Neurological Surgery Culpeper, VA Medical Doctor

NPI 1700066842 CMS profile 1038124

541 Sunset Ln Ste 305, Culpeper, VA 22701

Open in the dashboard

General payments

$2,091

26 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elisa Kucia of Culpeper, VA is reported in the CMS Open Payments database as having received $2,091 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 43rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23 1
2024 General $15 1
2023 General $21 1
2022 General $44 2
2021 General $1,090 7
2020 General $148 4
2019 General $751 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elisa Kucia
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Elisa Kucia were reported at $23. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Elisa Kucia Neurological Surgery median Middle half National median
2019 $751 $582 $138–$3,006 $163
2020 $148 $294 $76–$2,174 $114
2021 $1,090 $387 $105–$2,432 $132
2022 $44 $542 $139–$2,989 $149
2023 $21 $534 $145–$2,697 $160
2024 $15 $574 $155–$3,046 $164
2025 $23 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $1,040 5 payments
  2. Medtronic USA, Inc. $696 7 payments
  3. Stryker Corporation $172 4 payments
  4. DePuy Synthes Sales Inc. $63 3 payments
  5. Integra LifeSciences Corporation $34 2 payments
  6. Boston Scientific Corporation $23 1 payment
  7. Medtronic, Inc. $21 1 payment
  8. AxoGen $15 1 payment
  9. Misonix Inc $15 1 payment
  10. Orthofix Medical, Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,599 7 payments
  2. Food and Beverage $492 19 payments
Products named General payments · program years 2019–2025
  1. EXCELSIUS GPS $1,040 5 payments
  2. KYPHON Balloon Kyphoplasty $696 7 payments
  3. GENERAL K2M PRODUCT DISCUSSION $137 3 payments
  4. EVEREST SPINAL SYSTEM $36 1 payment
  5. EXPEDIUM $28 1 payment
  6. LIFENET VERTIGRAFT $28 1 payment
  7. MOUNTAINEER $28 1 payment
  8. WaveWriter Alpha Prime 16 $23 1 payment
  9. CODMAN CERTAS $23 1 payment
  10. CUSA CLARITY $23 1 payment
  11. Other $295 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

406

Median for Neurosurgery: 83

Drug cost

$2,575

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 129 $974
Tizanidine Hcl Generic 119 $681
Pregabalin Generic 24 $559
Meloxicam Generic 106 $210
Tramadol Hcl Generic 16 $81
Baclofen Generic 12 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$39,216

Medicare's payments for the services billed

Medicare patients

226

Average age 74

Services billed

449

137 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 28%
Depression 23%
Osteoporosis 23%
Ischemic heart disease 21%
Atrial fibrillation 19%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record